Article History
Received: 11 November 2020
Accepted: 23 December 2020
First Online: 12 March 2021
Compliance with ethical standards
:
: Marco Capobianco has received speaking honoraria and personal fees for contributing as an advisory board member from Almirall, Biogen, Merck-Serono, Mylan, Novartis, Roche, Sanofi-Genzyme, and TEVA. Antonio Bertolotto has received speaking honoraria and personal fees for contributing as an advisory board member from Almirall, Biogen, Merck-Serono, Mylan, Novartis, Roche, Sanofi-Genzyme, and TEVA. He also received research grant from Biogen, Novartis, Merck-Serono, Roche, and Sanofi-Genzyme. Simona Malucchi has received speaking honoraria and personal fees for contributing as an advisory board member from Almirall, Biogen, Merck-Serono, Mylan, Novartis, Roche, Sanofi-Genzyme, and TEVA. She also received research grant from Sanofi-Genzyme.
: Ethical approval was obtained from the local ethics committee of the University Hospital San Luigi in Orbassano.
: Informed consent to participate was obtained from legal guardians.
: Informed consent to publish was obtained from legal guardians.
: Not applicable